Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pauline Riviere

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Alimentary Pharmacology & Therapeutics|March 12, 2021
Letter: is the radiation therapy causing an IBD flare, or the IBD predisposing to radiation toxicity? Authors' replyDavid Laharie, Pauline Riviere
Alimentary Pharmacology & Therapeutics|October 5, 2020
Editorial: biologics in the therapy of Crohn's disease-the fog clearsDavid Laharie, Pauline Riviere
Alimentary Pharmacology & Therapeutics|December 8, 2022
Editorial: selecting therapy for ulcerative colitis-think a step aheadDavid Laharie, Pauline Riviere
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 6, 2018
Severe endoscopic lesions are not associated with more infliximab fecal loss in acute severe ulcerative colitisFlorian Poullenot, Dorothée Nivet, Stéphane Paul, et al.
Inflammatory Bowel Diseases|May 5, 2018
Proactive Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel DiseaseXavier Roblin, Pauline Riviere, Mathurin Flamant, et al.
Journal of Crohn'S & Colitis|September 25, 2019
Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-ResponseMiles P Sparrow, Konstantinos Papamichael, Mark G Ward, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Alimentary Pharmacology & Therapeutics|March 12, 2021
Letter: is the radiation therapy causing an IBD flare, or the IBD predisposing to radiation toxicity? Authors' replyDavid Laharie, Pauline Riviere
Alimentary Pharmacology & Therapeutics|October 5, 2020
Editorial: biologics in the therapy of Crohn's disease-the fog clearsDavid Laharie, Pauline Riviere
Alimentary Pharmacology & Therapeutics|December 8, 2022
Editorial: selecting therapy for ulcerative colitis-think a step aheadDavid Laharie, Pauline Riviere
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 6, 2018
Severe endoscopic lesions are not associated with more infliximab fecal loss in acute severe ulcerative colitisFlorian Poullenot, Dorothée Nivet, Stéphane Paul, et al.
Inflammatory Bowel Diseases|May 5, 2018
Proactive Therapeutic Drug Monitoring of TNF Antagonists in Inflammatory Bowel DiseaseXavier Roblin, Pauline Riviere, Mathurin Flamant, et al.
Journal of Crohn'S & Colitis|September 25, 2019
Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-ResponseMiles P Sparrow, Konstantinos Papamichael, Mark G Ward, et al.
Pageof 1